Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

KALU vs ABVX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

KALU Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 6–4 Matrix Metrics)

KALU Overall Winner 6-Pillar Tally: KALU 5 – 0 ABVX (1 Tie) Matrix Metrics: KALU 6 – 4 ABVX

As of Nov 19, 2026, Kaiser Aluminum Corporation (KALU) is the stronger overall head-to-head candidate over Abivax SA (ABVX) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). KALU carries a Unified Composite Score of 45.1/100 (HOLD) at $98.38 (27.7x Forward P/E, 7.6% operating margin), whereas ABVX carries 64.5/100 (BUY) at $80.65 (N/M Forward P/E, -6270.4% operating margin).

  • Composite vs. Pillar Nuance: While ABVX currently prints a higher short-term Unified Composite Score (64.5/100 BUY vs. KALU 45.1/100 HOLD), KALU captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (7.6% vs. -6270.4% operating margin) and revenue trajectory (+44.0% vs. -6.8% YoY).
  • Technical & Structure Timing Caution: KALU is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.6); meanwhile ABVX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About KALU vs ABVX
KALU NASDAQ Head-to-Head Winner
Kaiser Aluminum Corporation
Rolling Drawing & Extruding Of Nonferrous Metals
$98.38
-1.84% 1D
Market Cap $1.6B
TTM Revenue $4.51B
Forward P/E 27.7x
Beta / 30D Vol 1.91β · 104% Vol
Unified Composite Score
45.1 / 100 HOLD
Tech 47.0 Fund 58.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -13.5%), weak momentum, RSI 30
RSI-14: 29.6 · SMA20: $110.03 · SMA50: $134.17
ABVX NASDAQ
Abivax SA American Depositary Shares
Pharmaceutical Preparations
$80.65
-3.79% 1D
Market Cap $7.3B
TTM Revenue $4.7M
Forward P/E N/M
Beta / 30D Vol 1.46β · 44% Vol
Unified Composite Score
64.5 / 100 BUY
Tech 64.0 Fund 56.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -11.5%), weak momentum, RSI 37
RSI-14: 37.3 · SMA20: $86.82 · SMA50: $92.07

6-Pillar Scorecard Institutional Category Breakdown (KALU 5 – 0 ABVX)

Columns: Metric · KALU · ABVX
1. Valuation Multiples KALU
Forward P/E 27.7x N/M
Trailing P/E 7.8x N/M
PEG Ratio 1.17x N/M
EV / Revenue 0.4x N/M
2. Growth & Scale KALU
Revenue Growth (YoY) +44.0% -6.8%
Earnings Growth (YoY) -22.7% +0.0%
TTM Revenue (USD) $4.51B $4.7M
Market Cap $1.6B $7.3B
3. Profitability & Quality KALU
Gross Margin 13.4% 100.0%
Operating Margin 7.6% -6270.4%
Net Profit Margin 4.9% 0.0%
Return on Equity (ROE) 24.5% -252.3%
4. Balance Sheet & Cash Flow KALU
Cash Generation (TTM) $462M EBITDA -$292M EBITDA
Cash Flow Margin 10.3% EBITDA Mgn N/A
Net Cash / Leverage $60.22 Book/Sh · 24.5% ROE $5.16 Book/Sh · -252.3% ROE
Dividend Yield 3.01% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 19.1% (<1st %ile) 76.9% (<1st %ile)
Put/Call OI Skew N/A Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat KALU
OpEx & R&D Intensity 5.8% of Rev ($261M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Aluminum Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: KALU (6) vs ABVX (4)
Institutional Metric KALU ABVX Criterion Row Edge
Market Capitalization
Scale
$1.6B $7.3B Larger Scale ABVX
Trailing P/E Ratio
Valuation
7.8x N/M Lower Multiple KALU
Forward P/E Ratio
Valuation
27.7x N/M Lower Multiple KALU
Revenue Growth (YoY)
Growth
+44.0% -6.8% Higher Growth KALU
Operating Margin (TTM)
Profitability
7.6% -6270.4% Higher Margin KALU
Net Profit Margin
Profitability
4.9% 0.0% Higher Margin KALU
Return on Equity (ROE)
Capital Efficiency
24.5% -252.3% Higher ROE KALU
52-Week Range Position
Momentum
9% ($88–$200) 14% ($70–$149) Stronger Trend ABVX
Beta / 30D Volatility
Risk Regime
1.91β · 104% Vol 1.46β · 44% Vol Lower Realized Risk ABVX
Unified Institutional Score
Composite Signal
45.1 / 100 (HOLD) 64.5 / 100 (BUY) Higher Composite ABVX
Trailing 12M Revenue (USD)
Operating Scale
$4.51B $4.7M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
13.4% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.17x PEG · 0.4x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$462M EBITDA ($60.22 Book/Sh · 24.5% ROE) -$292M EBITDA ($5.16 Book/Sh · -252.3% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ABVX +22.37 pp
KALU: -36.1% · ABVX: -13.73%
3M Horizon ABVX +6.34 pp
KALU: -36.18% · ABVX: -29.84%
6M Horizon ABVX +6.94 pp
KALU: -41.92% · ABVX: -34.98%
1Y Horizon KALU +38.78 pp
KALU: +9.63% · ABVX: -29.15%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KALU vs ABVX. Trailing 12-month operating profitability (KALU 7.6% vs ABVX -6270.4%) and valuation multiples (KALU 27.7x vs ABVX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

KALU ADR TTM Benchmark FX-Normalized USD
TTM Revenue$4.51B
Gross Margin13.4%
Op. Margin7.6%
ROE / Fwd P/E24.5% · 27.7x
ABVX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$4.7M
Gross Margin100.0%
Op. Margin-6270.4%
ROE / Fwd P/E-252.3% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
KALU UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 19.1%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KALU Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ABVX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 76.9%
IV Percentile <1st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ABVX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
KALU Moat Profile Scale & Operating Efficiency Moat
Aluminum Operator
Competes within the Aluminum value chain with $1.6B market capitalization and 7.6% operating margin.
OpEx & R&D Reinvestment 5.8% of Rev ($261M)
90D Engineering Disclosures 0 Published
ABVX Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $7.3B market capitalization and -6270.4% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ KALU vs ABVX Key Questions & Quantitative Answers

As of Nov 19, 2026, Kaiser Aluminum Corporation (KALU) is the stronger overall head-to-head candidate over Abivax SA (ABVX) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). KALU carries a Unified Composite Score of 45.1/100 (HOLD) at $98.38 (27.7x Forward P/E, 7.6% operating margin), whereas ABVX carries 64.5/100 (BUY) at $80.65 (N/M Forward P/E, -6270.4% operating margin). Composite vs. Pillar Nuance: While ABVX currently prints a higher short-term Unified Composite Score (64.5/100 BUY vs. KALU 45.1/100 HOLD), KALU captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (7.6% vs. -6270.4% operating margin) and revenue trajectory (+44.0% vs. -6.8% YoY). Technical & Structure Timing Caution: KALU is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.6); meanwhile ABVX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

KALU leads the Growth & Scale pillar: KALU posts +44.0% YoY revenue growth and -22.7% YoY earnings growth on $4.51B TTM revenue (13.4% gross margin, 7.6% operating margin), compared with ABVX at -6.8% YoY revenue growth and +0.0% YoY earnings growth on $4.7M TTM revenue (100.0% gross margin, -6270.4% operating margin). On trailing 12-month operating scale, KALU generates $4.51B in USD-normalized revenue versus $4.7M for ABVX. In operating R&D and SG&A reinvestment, KALU deploys 5.8% of Rev ($261M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ABVX.

KALU screens cheaper on headline valuation multiples. KALU trades at 27.7x Forward P/E, 7.8x Trailing P/E, 1.17x PEG, and 0.4x EV/Revenue (10.3% EBITDA margin), whereas ABVX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KALU (24.5% ROE) versus ABVX (-252.3% ROE) capital efficiency.

In options market volatility and institutional positioning, KALU carries 19.1% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.91β · 104% Vol realized risk). By comparison, ABVX carries 76.9% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.46β · 44% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.